Vanberra Signal

Oxford Brain Diagnostics

Curated by Signal

Developer of a cortical disarray measurement platform

Overview

Oxford Brain Diagnostics is a developer of a platform for cortical disarray measurement for Alzheimer's therapy. The patented technology is used for the early detection of Alzheimer's disease. The platform analyses the data from the MRI data to provide patients’ brain health index for diagnosing for differential diagnosis between dementias such as Alzheimer’s disease and frontotemporal dementia.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of personalised nutritional supplements to improve health

    Life Sciences TechnologyLondon, United Kingdom
  • Developer of therapeutic solutions and healthcare products for muscle contraction and relaxation in horses

    Life Sciences TechnologyUnited Kingdom
  • AI-based navigation solutions for assisting doctors in neurosurgery

    Life Sciences TechnologyLiverpool, United Kingdom

About Oxford Brain Diagnostics

What does Oxford Brain Diagnostics do?

Oxford Brain Diagnostics is a developer of a platform for cortical disarray measurement for Alzheimer's therapy.

Where is Oxford Brain Diagnostics headquartered?

Oxford Brain Diagnostics is headquartered in Oxford, United Kingdom.

When was Oxford Brain Diagnostics founded?

Oxford Brain Diagnostics was founded in 2019.

Which sector is Oxford Brain Diagnostics in?

Oxford Brain Diagnostics operates in Life Sciences Technology.

Who are Oxford Brain Diagnostics's competitors?

Companies similar to Oxford Brain Diagnostics include MYOFORM, Theraplate, and NeuroNav.